Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Journal of Affective Disorders
|
October 16, 2025
Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis
Leo R Silberbauer, Benjamin Eggerstorfer, Paul Michenthaler, et al.
Frontiers in Pharmacology
|
July 19, 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
Mario Karolyi, Sara Omid, Erich Pawelka, et al.
Journal of the American College of Cardiology
|
December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial
Eva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
Translational Psychiatry
|
February 3, 2026
Acute effects of selective serotonin reuptake inhibitors on cerebral glucose metabolism and blood flow
Leo R Silberbauer, Murray B Reed, Gregor Gryglewski, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 10, 2023
Plasma and intraperitoneal pharmacokinetics of ceftazidime/avibactam in peritoneal dialysis patients
Valentin Al Jalali, Peter Matzneller, Anh Duc Pham, et al.
Frontiers in Neuroscience
|
April 12, 2021
Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla
Petr Bednarik, Benjamin Spurny, Leo R Silberbauer, et al.
Journal of Hepatology
|
March 15, 2023
Corrigendum to "Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease" [J Hepatol 77 (2022) 918-930]
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Journal of Hepatology
|
May 23, 2022
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Clinical Pharmacology and Therapeutics
|
September 16, 2017
Clopidogrel in Critically Ill Patients
Christian Schoergenhofer, Eva-Luise Hobl, Peter Schellongowski, et al.
Frontiers in Psychiatry
|
October 26, 2020
Effect of Ketamine on Limbic GABA and Glutamate: A Human <i>In Vivo</i> Multivoxel Magnetic Resonance Spectroscopy Study
Leo R Silberbauer, Benjamin Spurny, Patricia Handschuh, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Journal of Affective Disorders
|
October 16, 2025
Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis
Leo R Silberbauer, Benjamin Eggerstorfer, Paul Michenthaler, et al.
Frontiers in Pharmacology
|
July 19, 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
Mario Karolyi, Sara Omid, Erich Pawelka, et al.
Journal of the American College of Cardiology
|
December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial
Eva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
Translational Psychiatry
|
February 3, 2026
Acute effects of selective serotonin reuptake inhibitors on cerebral glucose metabolism and blood flow
Leo R Silberbauer, Murray B Reed, Gregor Gryglewski, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 10, 2023
Plasma and intraperitoneal pharmacokinetics of ceftazidime/avibactam in peritoneal dialysis patients
Valentin Al Jalali, Peter Matzneller, Anh Duc Pham, et al.
Frontiers in Neuroscience
|
April 12, 2021
Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla
Petr Bednarik, Benjamin Spurny, Leo R Silberbauer, et al.
Journal of Hepatology
|
March 15, 2023
Corrigendum to "Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease" [J Hepatol 77 (2022) 918-930]
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Journal of Hepatology
|
May 23, 2022
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Clinical Pharmacology and Therapeutics
|
September 16, 2017
Clopidogrel in Critically Ill Patients
Christian Schoergenhofer, Eva-Luise Hobl, Peter Schellongowski, et al.
Frontiers in Psychiatry
|
October 26, 2020
Effect of Ketamine on Limbic GABA and Glutamate: A Human <i>In Vivo</i> Multivoxel Magnetic Resonance Spectroscopy Study
Leo R Silberbauer, Benjamin Spurny, Patricia Handschuh, et al.
Page
of 5